In glioma cell lines (i.e., U87-MG, U251, ln18, and U373), UBE2C, a known glioma tumor progression protein, harbors two FOXM1 binding sites on its promoter, strongly suggesting that it could be another direct transcriptional target of FOXM1. This evidence concerns the gene UBE2C and glioma.